# Predictors of Response to Iron and Erythropoietin Stimulating Agents

> **NCT03658876** · PHASE4 · COMPLETED · sponsor: **Imperial College London** · enrollment: 197 (actual)

## Conditions studied

- Renal Failure Chronic
- Anemia

## Interventions

- **DRUG:** Iron Sucrose Solution for Injection
- **DRUG:** Epoetin Beta

## Key facts

- **NCT ID:** NCT03658876
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-03
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03658876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03658876, "Predictors of Response to Iron and Erythropoietin Stimulating Agents". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03658876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*